Volume 41, Issue 12 | PharmacoEconomics

Search all PharmacoEconomics articles

Volume 41, Issue 12

December 2023

Filter by

Volume:

Sort by

Date published:

New to old Old to new

9 articles in this issue

The Carer QALY Trap and Altruism in Economic Evaluations
J. Mick Tilford
Aygul Tarlan
Editorial 02 November 2023 Pages: 1553 - 1555
Modelling Spillover Effects on Informal Carers: The Carer QALY Trap
David J. Mott
Hannah Schirrmacher
Chris Skedgel
Current Opinion Open access 02 September 2023 Pages: 1557 - 1561
Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies
Deborah A. Marshall
Brittany Gerber
Gillian R. Currie
Scoping Review 18 August 2023 Pages: 1563 - 1588
Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations
Kumar Mukherjee
Necdet B. Gunsoy
Gian Luca Di Tanna
Systematic Review Open access 25 July 2023 Pages: 1589 - 1601
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens
David Teigen
Robert O. Opoka
Bjarne Robberstad
Original Research Article Open access 18 July 2023 Pages: 1603 - 1615
Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework
Boshen Jiao
Original Research Article 25 July 2023 Pages: 1617 - 1627
De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation
Peter Gal
Gyorgyi Feldmajer
Inger Smith
Original Research Article Open access 28 July 2023 Pages: 1629 - 1639
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland
Michaela Carla Barbier
Alicia Fengler
Oliver Gautschi
Original Research Article Open access 12 August 2023 Pages: 1641 - 1655
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom
Jason Gordon
Maria Gheorghe
Amer Al-Taie
Original Research Article Open access 16 August 2023 Pages: 1657 - 1673